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Nature of the Problem
The unique vulnerability of the developing
brain to environmental agents at exposure lev-
els that have no lasting effect in the adult is
well established. Long-lasting damage to brain
development and function caused by prenatal
alcohol exposure, for example, was recognized
centuries ago. In the Old Testament (Judges
13:7) we find: “Behold, thou shalt conceive
and bear a son; and now drink no wine or
strong drink.” In 1726, the College of
Physicians Report to the British Parliament
described parental drinking as a “cause of
weak, feeble, and distempered children” (1). 
Studying neurodevelopmental vulnerabili-
ties in children, however, is challenging.
Varying deﬁnitions of end points, nonspeciﬁc
end points caused by multiple factors, lack of
exposure and effect surveillance data, con-
founders and effect modifiers, and long
latency periods between exposures and out-
comes complicate attempts to reach deﬁnitive
conclusions through epidemiologic studies.
Even when a significant association is estab-
lished, researchers often disagree about when
causality has been demonstrated or what the
shape of a dose–response curve might be. As a
result, estimates of thresholds and reference
or benchmark doses are often a matter of
debate and vary as a function of the outcome
of interest. 
Considerable attention is being focused on
the neurodevelopmental effects of prenatal and
childhood exposures to a variety of contami-
nants in the ambient environment. This inter-
est is sparked partly by a growing recognition
of an apparent increase in the incidence of
developmental disabilities. In the United States
nearly 12 million children under 18 years of
age (17%) suffer from deafness, blindness,
epilepsy, speech deﬁcits, cerebral palsy, delays
in growth and development, emotional or
behavioral problems, or learning disabilities
(2). Learning disabilities alone affect 5–10% of
children in public schools (3). Attention deﬁcit
hyperactivity disorder (ADHD) conservatively
affects 3–6% of all school children and perhaps
as many as 17% (4). The use of Ritalin for this
disorder has doubled every 4–7 years since
1971 (5). The incidence of autism may be as
high as 2 per 1,000 children. The number of
children entered into the California autism
registry increased by 210% between 1987 and
1998 (6). Improved reporting and differing
diagnostic criteria may explain some but not
all of these trends (7).
Genetic, environmental, and social
factors interacting in complex ways are
important determinants of cognitive devel-
opment and behavior. None alone is suffi-
cient to explain populationwide increases in
neurodevelopmental abnormalities. Except
for single-gene disorders, heredity accounts
for, at most, about 50% of the variance of
cognitive, behavioral, and personality traits
among individuals (8). This, of course,
implies that the other 50% of variability
must be due to environmental inﬂuences. 
Insights gained from molecular biology,
chromosome analysis, and twin studies shed
some light on genetic influences and gene–
environment interactions. Phenylketonuria is
an example of a single-gene disorder in which
mental retardation results from an inherited
inability to metabolize phenylalanine. In this
disease an environmental intervention,
removing phenylalanine from the diet, com-
pletely prevents the neurologic impacts. Is
this a genetic or an environmental disorder? 
More commonly, multiple subtly acting
genes working together exert smaller influ-
ences over neurologic development. Genetic
polymorphisms that influence metabolic
enzyme levels help to explain some popula-
tionwide variance to susceptibility to toxic
exposures such as, for example, exposure to
organophosphate pesticides (9,10). A grow-
ing understanding of the syndrome called
PANDAS (pediatric autoimmune neuro-
psychiatric disorders associated with strepto-
coccal infections) suggests that some
children with a particular antigenic marker
on B lymphocytes are particularly suscepti-
ble to repetitive, obsessive–compulsive
behaviors, tics, and Tourette syndrome after
a streptococcal infection—another example
of gene–environment interactions (11). 
Among the problems that interfere with
more complete understanding of the inci-
dence and etiology of neurodevelopmental
disorders is the inconsistent use of diagnostic
labels that results when symptoms of concern
are of variable severity and, collectively, only
partially match diagnostic criteria. Behavioral
problems, for example, may range from mild
attention deﬁcits to severe conduct disorders.
Developmental problems may span a spec-
trum from mild impairment of social skills to
severe and disabling autism. Learning-related
disorders may be isolated or mild and speciﬁc,
or associated with severe mental retardation.
Moreover, some traits typical of one diagnos-
tic category are likely to be found in another
as well. For example, up to 30% of children
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with ADHD have a learning disability and
30–80% have a conduct disorder (12). 
Toxicologic studies in laboratory animals
or humans typically attempt to identify speciﬁc
traits rather than syndromes that result from
exposures. Conversely, healthcare providers
and educators are more likely to search for
diagnostic categories that best encompass the
constellation of traits that they identify in an
individual. ADHD, for example, is manifest as
a mixture of attentional problems and
impaired impulse control. Toxicologists are
more readily able to study and report the
impacts of chemical exposure on discrete tests
of attention than on a mixture of attentional
and behavioral problems. Differing discipli-
nary approaches contribute to a lack of com-
munication, as well as complicating clinical or
laboratory research and populationwide moni-
toring of trends. For the purposes of studying
etiologies and opportunities for prevention of
developmental disabilities, explicit considera-
tion of traits, as well as diagnostic categories,
will provide important insights. 
Speciﬁc Developmental
Toxicants
Brain development begins early in embryonic
life and continues well beyond birth into ado-
lescence. During development, brain cells
divide, migrate, differentiate, establish synap-
tic connections, and undergo programmed
cell death (apoptosis) in an orchestrated
sequence of events controlled by neuro-
transmitters and other neurotrophic factors.
Interference with any stage of this cascade of
events may alter subsequent stages, so that
even short-term disruptions may have long-
term effects later in life. 
Despite the challenges inherent in studying
neurodevelopmental disorders in children, a
large literature conclusively documents the
effects of a few environmental agents (7). It
is, for example, well established that fetal or
infant exposure to lead, alcohol, or nicotine
impairs normal neuropsychologic develop-
ment. Fetal alcohol exposure causes hyper-
activity and cognitive deficits (13).
Maternal smoking causes intelligence quo-
tient (IQ), learning, and attention deficits
in offspring (14). Early-life lead exposure
decreases learning, attention, and IQ and
contributes to hyperactivity, impulsiveness,
and aggression (15,16).
Mercury
Mercury (Hg) is a potent neurodevelopmental
toxicant commonly encountered as dietary
methylmercury, which adversely affects
enzymes, cellular membrane function, and
neurotransmitter levels (17,18). Mercury
causes oxidative stress, lipid peroxidation, and
mitochondrial dysfunction and disrupts
synaptic transmission, microtubule formation,
amino acid transport, and cellular migration
in the developing brain (19). In a prolonged
poisoning episode in Japan and a more acute
episode in Iraq, large prenatal methylmercury
exposures were associated with psychomotor
retardation, seizures, developmental delays,
and mental retardation (20,21). Much smaller
prenatal exposures from maternal consump-
tion of contaminated fish in New Zealand
(mean maternal hair level Hg 8.3 ppm) and
the Faroe Islands (mean maternal hair level
Hg 4.3 ppm) adversely affected IQ, language
development, visual–spatial skills, gross motor
skills, memory, and attention in offspring
(22,23). A study in the Seychelle Islands
(mean maternal hair level Hg 5.9 ppm)
showed no adverse effects on child neurologic
development at 5 years of age (24). 
As with lead, a historical review of our
understanding of the neurodevelopmental
toxicity of mercury shows that more refined
testing has resulted in a steady decline in the
exposure level thought to be “safe” and with-
out adverse effects. The U.S. Environmental
Protection Agency (U.S. EPA) has recently
developed a reference dose for mercury of
0.1 µg Hg/kg/day and estimates that mercury
exposures at this level are likely to result in
hair mercury levels of about 1.0 ppm.
Maternal exposures at or below this level are
thought unlikely to increase the risk of harm
to the developing fetal brain. A committee of
the National Academy of Sciences has
afﬁrmed and supported the derivation of this
reference dose (25). The U.S. EPA estimates,
unfortunately, that 52,000–166,000 pregnant
women in the United States consume fish
contaminated with mercury at levels at or
above this reference dose (26).
Manganese
The central nervous toxicity of manganese
(Mn) due to occupational exposures is well
characterized. Symptoms include gait and
movement disorders, and in some cases, inap-
propriate behavior. More recently, the devel-
opmental neurotoxicity of manganese has
emerged as a significant public health con-
cern. In several small epidemiologic studies of
children, manganese hair levels are associated
with ADHD (27–29). Developmental expo-
sure to manganese in laboratory animals is
associated with hyperactivity (30). 
At low levels, manganese is an essential
dietary trace element necessary for critical
enzymatic reactions. The concentration of
manganese in human breast milk is about
6µ g Mn/L, whereas infant formula may con-
tain 77–100 µg Mn/L, depending on whether
it has been supplemented; soy formula may
naturally contain as much as 200–300 µg
Mn/L (31,32). Compared to adults, children
and immature animals absorb more and
excrete less manganese (33,34). Moreover, in
infants, manganese easily gains access to the
developing brain because of an immature
blood–brain barrier. 
These observations raise questions about
the wisdom of supplementing infant formula
with manganese and the widespread use of
infant soy formula containing naturally high
concentrations of manganese. They also fur-
ther concerns about the use of gasoline sup-
plemented with an organic manganese
compound as an octane enhancer in the
United States and Canada. The Ethyl
Corporation (Richmond, VA, USA), the
U.S.-based manufacturer of the additive,
claims there is no evidence to support con-
cerns that manganese in gasoline represents a
threat to public health—an argument that is
eerily reminiscent of their position on the use
of tetraethyl lead many years ago. Under pro-
visions of the North American Free Trade
Agreement (NAFTA) (35), the Ethyl
Corporation brought legal action against
Health Canada for blocking access to
Canada’s gasoline market. Health Canada
ultimately decided to settle, not only allowing
the additive onto the market but also agreeing
to pay Ethyl Corporation an estimated $10
million for legal costs and lost income (36).
Meanwhile, available data indicate that the
brain is vulnerable to long-lasting effects from
developmental exposures to manganese. 
Polychlorinated Biphenyls
The adverse neurodevelopmental impacts of
polychlorinated biphenyls (PCBs) have been
examined in several large epidemiologic
studies. In humans, developmental exposures
to PCBs at ambient environmental levels
cause hyporeflexia, psychomotor delays,
delayed cognitive development, and IQ
deficits (37–41). Impaired learning, altered
behavior, and hyperactivity have been
demonstrated in laboratory animals (42,43). 
PCBs are likely to exert their adverse
effects through a variety of mechanisms.
Co-planar PCBs may interact with the aryl
hydrocarbon receptor and exert dioxinlike
effects. PCBs also alter thyroid hormone
metabolism and may interfere with thyroid
hormone-induced gene transcription (44). In
humans, seals, rodents, and birds, PCB expo-
sure causes decreased thyroid hormone levels
(45,46). Some PCBs also alter neurotrans-
mitter levels (47). For example, ortho-PCBs
decrease dopamine synthesis, whereas
non-ortho-PCBs increase dopamine levels.
Because thyroid hormone is essential for
normal brain development, the effects of
PCBs and other chemicals that interfere with
thyroid hormone homeostasis are of particular
concern. A recent study by Haddow et al. (48)
of women with hypothyroidism during preg-
nancy showed the extreme sensitivity of the
developing brain to even mildly depressed orToxic threats to child development
low-normal thyroid hormone levels. At 7–9
years of age, offspring of these women were
more likely than the offspring of mothers with
normal thyroid function to perform poorly on
tests of attention and word discrimination.
Haddow and co-workers used elevated serum
thyrotropin (TSH) levels to identify hypothy-
roid women. Elevated TSH levels correlated
with lower total and free thyroxine levels. 
In the study by Koopman-Esseboom et al.
(49) of ambient environmental levels of PCBs
on maternal and infant thyroid function,
PCB exposures significantly correlated with
decreased maternal triiodothyronine (T3) lev-
els but not with maternal thyroxine (T4) or
TSH (49). However, higher maternal PCB
exposures signiﬁcantly correlated with higher
TSH levels in infants 2 and 3 months of age. 
Polybrominated diphenyl ethers (PBDEs—
widely used as flame retardants in consumer
products and detected in increasing concentra-
tions in human breast milk) and certain pesti-
cides such as dicofol, pentachlorophenol,
dinoseb, and bromoxynil, competitively bind
with the thyroid hormone binding protein,
transthyretin (50). Some bind more avidly
than T4, displacing T4 and potentially interfer-
ing with its transport to the developing brain.
The developmental neurotoxicity of these sub-
stances has not been studied to any appreciable
degree, yet human exposures to PBDE and
pentachlorophenol are widespread (51,52). 
Pesticides
Limited data are available describing the effects
of developmental exposures to neurotoxic pesti-
cides on subsequent brain function. In rodents
a single low-level exposure to an organophos-
phate pesticide or a pyrethroid on day 10 of life
causes permanent decreases in brain cholinergic
receptors and hyperactivity when the animal is
tested at 4 months of age (53,54). A limited
ecologic study of Mexican children exposed
developmentally to a mixture of agricultural
chemicals showed adverse effects on motor
skills, memory, attention, and learning (55).
The general lack of neurodevelopmental toxic-
ity data for agricultural chemicals is of particu-
lar concern because of their widespread use and
ubiquitous exposures. Population-based studies
in the United States show that over 90% of
children have detectable urinary residues of just
one of the neurotoxic organophosphate pesti-
cides. Specimens analyzed for residues of 30
pesticides showed that >50% of the population
contained at least six (53).
Conclusions
Developmental delays, learning disabilities,
ADHD, and behavioral disorders extract a
terrible toll from children, families, and soci-
ety (56). Children with ADHD are at risk for
failure in the classroom and later in the work-
place. Individuals with learning disabilities
have a more difficult time keeping a job,
learning new skills, and getting along with co-
workers. Children with learning disabilities
are often alienated, isolated, and misunder-
stood. Some developmental disabilities
increase the risk of substance abuse, delin-
quency, criminal behavior, and suicide. 
Families of children with learning, devel-
opmental, or behavioral disorders experience
additional stress. The costs associated with
caring for these children can be high for fami-
lies and society. Special education programs
and psychologic and medical services drain
resources. When services are unavailable, chil-
dren, families, and communities suffer in
numerous ways. 
As the science of neurodevelopment slowly
evolves, questions about appropriate preventive
actions deserve consideration. The neurodevel-
opmental effects of relatively few compounds
encountered in the ambient environment are
well characterized. Yet, even these limited data
highlight the profound vulnerability of the
developing brain. Moreover, comparisons of
animal and human data for lead, mercury, and
PCBs show that laboratory animal studies tend
to underestimate human neurodevelopmental
sensitivity by 2–4 orders of magnitude (57). In
each case, reference or benchmark doses were
continuously revised downward as human data
were developed. Unfortunately, neurodevelop-
mental data are lacking for the large majority
of known or suspected neurotoxicants.
Regulatory agencies have generally failed to
require neurodevelopmental testing of chemi-
cals before they are marketed. None of the vol-
untary testing programs proposed by the
chemical industry in the United States
includes neurodevelopmental testing.
In its Sixth Biennial Report on Great Lakes
Water Quality (58), the International Joint
Commission (IJC) advocated a weight of evi-
dence approach to the identification of sub-
stances that may cause harm. They found it
disingenuous that science must prove with
100% certainty that an exposure will result in
an adverse health effect before taking precau-
tionary action. They concluded, “. . . the focus
must be on preventing the generation of persis-
tent toxic substances in the ﬁrst place, rather
than trying to control their use, release, and
disposal after they are produced.” They
endorsed the precautionary principle that, with
evidence of threats of signiﬁcant harm, even in
the face of scientiﬁc uncertainty, precautionary
action should be taken to protect public health
and the environment. However, Gordon
Durnil, former chair of the IJC, described the
response strategy of industry lobbyists as the
three Ds—deny, divert, delay (59).
Although we can do little about genetic
contributions to many of these developmen-
tal disorders, we have enormous opportuni-
ties to mitigate environmental factors.
Sufficient evidence has been accumulated to
permit better understanding of the hazards of
exposure to neurotoxic chemicals. Clearly,
more comprehensive pre- and postmarket
neurodevelopmental testing of chemicals to
which humans and wildlife are likely to be
exposed is essential. Residual uncertainties,
however, cannot be an excuse for avoiding
precautionary action when available evidence
establishes the plausibility of harm. 
REFERENCES AND NOTES
1.  Nulman I, O’Hayon, Gladstone J, Koren G. The effects of alco-
hol on the fetal brain. In: Handbook of Developmental
Neurotoxicology (Slikker W, Chang L, eds). San Diego,
CA:Academic Press, 1998.
2.  Boyle C, Decoufﬂe P, Yeargin-Allsopp M. Prevalence and health
impact of developmental disabilities in US children. Pediatrics
93(3):399–403 (1994).
3.  Parrill M. Research implications for health and human services.
In: Learning Disabilities, Lifelong Issues (Cramer S, Ellis W,
eds). Baltimore, MD: Paul W. Brookes Publishing, 1996. 
4.  Goldman L, Genel M, Bezman R, Slanetz P. Diagnosis and treat-
ment of attention deficit hyperactivity disorder in children and
adolescents. J Am Med Assoc 279(14):1100–1107 (1998).
5.  Safer D, Zito J, Fine E. Increased methylphenidate usage for
attention deficit disorder in the 1990’s. Pediatrics
98(6):1084–1088 (1996).
6.  California Health and Human Services. Changes in the
Population of Persons with Autism and Pervasive Development
Disorders in California’s Developmental Services System: 1987
through 1998. A Report to the Legislature, March 1999.
Available: http://www.dds.cahwnet.gov/Autism/main/inciden-
crptﬁnal.pdf [cited 26 October 2001].
7.  Schettler T, Stein J, Reich F, Valenti M. In Harm’s Way: Toxic
Threats to Child Development. Boston: Greater Boston
Physicians for Social Responsibility, 2000. Available:
http://www.igc.org/psr and all primary references cited therein
[cited 26 October 2001]. 
8.  Plomin R, Owen M, McGuffin P. The genetic basis of complex
human behaviors. Science 264:1733–1739 (1994).
9.  Rosenman K, Guss P. Prevalence of congenital deficiency in
serum cholinesterase. Arch Environ Health 52(1):42–44 (1997). 
10.  Costa L, Li W, Richter R, Shih D, Lusis A, Furlong C. The role of
paraoxonase (PON1) in the detoxiﬁcation of organophosphates
and its human polymorphism. Chem-Biol Interact 119–120:
429–438 (1999). 
11. Trifiletti R, Packard A. Immune mechanisms in pediatric neu-
ropsychiatric disorders. Tourette’s syndrome, OCD, and PAN-
DAS. Child Adolesc Psychiatr Clin North Am 8(4):767–775
(1999).
12.  Baumgaertel A, Copeland L, Wolwraich M. Attention deficit
hyperactivity disorder. In: Disorders of Development and
Learning, 2nd ed (Wolraich M, ed). St. Louis, MO:Mosby, 1996. 
13.  Nulman I, O’Haydon B, Gladstone J, Koren G. The effects of
alcohol in the fetal brain. In: Handbook of Developmental
Neurotoxicology (Slikker W, Chang LW, eds). San Diego,
CA:Academic Press, 1998.
14.  Eskenazi B, Castorina R. Association of prenatal maternal or
postnatal child environmental tobacco smoke exposure and
neurodevelopmental and behavioral problems in children.
Environ Health Perspect 107:991–1000 (1999).
15.  Rice DC. Developmental lead exposure: neurobehavioral conse-
quences. In: Handbook of Developmental Neurotoxicology
(Slikker W, Chang LW, eds). San Diego, CA:Academic Press,
1998.
16.  Needleman HL, Reiss JA, Tobin MJ, Biesecher G, Greenhouse
J. Bone lead levels and delinquent behavior. JAMA
275:363–369 (1996).
17.  Atchison WD, Hare MF. Mechanisms of methylmercury-induced
neurotoxicity. FASEB J 8(9):622–629 (1994).
18.  Sager PR. Selectivity of methylmercury effects on cytoskeleton
and mitotic progression in cultured cells. Toxicol Appl Pharm
94(3):473–486 (1988).
19.  Sager PR, Matheson DW. Mechanisms of neurotoxicity related
to selective disruption of microtubules and intermediate fila-
ments. Toxicology 49(2–3):479–492 (1988).
20.  Harada H. Congenital Minamata disease: intrauterine
methylmercury poisoning. Teratology 18:285–288 (1978).
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 6 | December 2001 815Schettler
816 VOLUME 109 | SUPPLEMENT 6 | December 2001 • Environmental Health Perspectives
21.  Amin-Zaki L, Ehassani S, Majeed MA, Clarkson T, Doherty R,
Greenwood M, Giovanoli-Jakubezak T. Perinatal methylmercury
poisoning in Iraq. Am J Dis Child 130:1070–1076 (1976).
22.  Crump KS, Kjellstrom T, Shipp AM, Silvers A, Stewart A.
Influence of prenatal mercury exposure upon scholastic and
psychological test performance: benchmark analysis of a New
Zealand cohort. Risk Anal 18(6):701–713 (1998).
23.  Grandjean P, Weihe P, White R, Debes F, Araki S, Yokohama K,
Murata K, Sorensen N, Dahl R. Cognitive deficit in 7-year-old
children with prenatal exposure to methylmercury. Neurotoxicol
Teratol 19(6):417–428 (1997).
24.  Davidson PW, Myers GJ, Cox C, Axtell C, Shamlaye C, Sloane-
Reeves J, Cernichiari E, Needham L, Choi A, Wang Y, et al.
Effects of prenatal and postnatal methylmercury exposure from
ﬁsh consumption on neurodevelopment: outcomes at 66 months
of age in the Seychelles Child Development Study. JAMA
280(8):701–707 (1998). 
25.  National Research Council. Toxicological Effects of
Methylmercury. Washington, DC:National Academy Press,
2000.
26.  U.S. EPA. Mercury Study Report to Congress. EPA-452/R-97-003.
Washington, DC:U.S. Environmental Protection Agency, 1997. 
27.  Collipp PJ, Chen SY, Maitinsky S. Manganese in infant formu-
las and learning disability. Ann Nutri Metab 27:488–494 (1983).
28.  Pihl RO, Parkes M. Hair element content in learning disabled
children. Science 198:204–206 (1977).
29.  Crinella FM, Cordova EJ, Ericson JE. Manganese, aggression,
and attention-deficit hyperactivity disorder. Neurotoxicology
19(3):468–469 (1998).
30.  Boyes WK, Miller DB. A review of rodent models of manganese
meurotoxicity. NeuroToxicology 19(3):468 (1998).
31.  Dorner K, Dziadzka S, Hohn A, Sievers E, Oldigs H, Schulz-Lell
G, Schaub J. Longitudinal manganese and copper balances in
young infants and preterm infants fed on breast milk and
adapted cow’s milk formula. Br J Nutr 61(3):559–572 (1989).
32.  Lonnerdal B. Nutritional aspects of soy formula. Acta Pediatr
Suppl 402:105–108 (1994).
33.  Mena I. The role of manganese in human disease. Ann Clin Lab
Sci 4(6):487–491 (1974).
34.  Dorner K, Dziadzka S, Hohn A, Sievers E, Oldigs H, Schulz-Lell G,
Schaub J. Longitudinal manganese and copper balances in
young infants and preterm infants fed on breast milk and
adapted cow’s milk formula. Br J Nutrition 61(3):559–572 (1989).
35.  International Joint Commission United States and Canada.
Great Lakes Water Quality Agreement, 1972; renewed 1978.
36. McCarthy S. Threat of NAFTA case kills Canada’s MMT ban.
The Globe and Mail. p. a1. July 20, 1998.
37.  Jacobson JL, Jacobson SW. Effects of in utero exposure to
PCBs and related contaminants on cognitive functioning in
young children. J Pediatr 116(1):38–45 (1990).
38.  Jacobson JL, Jacobson SW. Intellectual impairment in children
exposed to polychlorinated biphenyls in utero. N Engl J Med
335:783–789 (1996).
39.  Patandin S, Lanting CI, Mulder PG, Boersma E, Sauer P,
Weisglas-Kuperus N. Effects of environmental exposure to poly-
chlorinated biphenyls and dioxins on cognitive abilities in Dutch
children at 42 months of age. J Pediatr 134(1):33–41 (1999).
40.  Lonky E, Reihman J, Darvill T. Neonatal behavioral assessment
scale performance in humans inﬂuenced by maternal consump-
tion of environmentally contaminated Lake Ontario ﬁsh. J Great
Lakes Res 22(2):198–212 (1996).
41.  Stewart P, Reihman J, Lonky E, Darvill T, Pagano J. Prenatal
PCB exposure and neonatal behavioral assessment scale
(NBAS) performance. Neurotoxicol Teratol 22(1):21–29 (2000).
42.  Rice DC, Hayward S. Effects of postnatal exposure to a PCB mix-
ture in monkeys on nonspatial discrimination reversal and
delayed alternation performance. NeuroToxicology 18(2):479–494
(1997).
43.  Rice DC. Behavioral impairment produced by low-level postna-
tal PCB exposure in monkeys. Environ Res (sect A) 80:S113–121
(1999).
44.  Zoeller RT, Dowling A, Vas A. Developmental exposure to poly-
chlorinated biphenyls exerts thyroid hormone-like effects on the
expression of RC3/neurogranin and myelin basic protein mes-
senger ribonucleic acids in the developing rat brain.
Endocrinology 141(1):181–189 (2000).
45.  Brouwer A, Longnecker M, Birnbaum L, Cogliano J, Kostyniak P,
Moore J, Schantz S, Winneke G. Characterization of potential
endocrine-related health effects at low-dose levels of exposure
to PCBs. Environ Health Perspect 107(suppl 4):639–648 (1999).
46.  Osius N, Karmaus W, Kruse H, Witten J. Exposure to polychlori-
nated biphenyls and levels of thyroid hormones in children.
Environ Health Perspect 107:843–849 (1999).
47.  Tilson HA. Neurochemical effects of PCBs—an overview.
NeuroToxicology 18(3):727–744 (1997).
48.  Haddow JE, Palomaki GE, Allan W, Williams J, Knight G,
Gagnon J, O’Heir C, Mitchell M, Hermos R, Waisbren S, et al.
Maternal thyroid deficiency during pregnancy and subsequent
neuropsychological development of the child. N Engl J Med
341(8):549–555 (1999). 
49.  Koopman-Esseboom C, Morse D, Weisglas-Kuperus N,
Lutkeschipholt I, van der Paauw C, Tuinstra L, Brouwer A, Sauer
P. Effects of dioxins and polychlorinated biphenyls on thyroid
hormone status of pregnant women and their infants. Pediatr
Res 36:468–473 (1994)
50.  Meerts T, van Zanden J, Luijks E, van Leeuwen-Bol I, Marsh G,
Jakobsson E, Bergman A. Potent competitive interactions of
some brominated ﬂame retardants and related compounds with
human transthyretin in vitro. Toxicol Sci 56:95–104 (2000).
51.  Darnerud P, Eriksen G, Johannesson T, Larsen P, Viluksela M.
Polybrominated diphenyl ethers: occurrence, dietary exposure,
and toxicity. Environ Health Perspect 109(suppl 1):49–68 (2001) 
52.  Needham L, Hill R, Ashley D, Pirkle J, Sampson E. The priority
toxicant reference range study: interim report. Environ Health
Perspect 103(suppl 3):89–94 (1995).
53.  Ahlbom J, Fredriksson A, Eriksson P. Exposure to an
organophosphate (DFP) during a deﬁned period in neonatal life
indusces permanent changes in brain muscarinic receptors and
behaviour in adult mice. Brain Res 677:13–19 (1995).
54.  Eriksson P, Fredriksson A. Neurotoxic effects of two different
pyrethroids, bioallethrin and deltamethrin, on immature and
adult mice: changes in behavioural and muscarinic receptor
variables. Toxicol Appl Pharmacol 108:78–85 (1991).
55.  Guillette EA, Meza MM, Aquilar MG, Soto AD, Enedina I. An
anthropological approach to the evaluation of preschool chil-
dren exposed to pesticides in Mexico. Environ Health Perspect
106:347–353 (1998). 
56.  Cramer S, Ellis E, eds. Learning Disabilities: Lifelong Issues.
Baltimore, MD:Paul H. Brookes Publishing, 1996.
57.  Rice D, Evangelista de Duffard A, Duffard R, Iregren A, Satoh H,
Watanabe C. Lessons for neurotoxicology from selected model
compounds: SGOMSEC joint report. Environ Health Perspect
104(suppl 2):205–215 (1996).
58. International Joint Commission. Sixth Biennial Report on Great
Lakes Water Quality. Windsor, Ontario:IJC, 1992.
59.  Durnil G. How much information do we need before exercising
precaution? In: Protecting Public Health and the Environment:
Implementing the Precautionary Principle (Raffensperger C,
Tickner J, eds). Washington, DC:Island Press, 1999. 